All Stories

  1. Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library
  2. Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure
  3. OR01: N-3 Polyunsaturated (N-3 PUFA) Fatty Acid Enrichment Prevents Intravenous Lipid-Induced Acute Stimulation of Mitochondrial Reactive Oxygen Species Generation and Lowers ATP Production in Rat Skeletal Muscle
  4. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease
  5. In Vivo Functional Selection Identifies Cardiotrophin-1 as a Cardiac Engraftment Factor for Mesenchymal Stromal Cells
  6. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model
  7. OR12: Unacylated Ghrelin Normalizes Uremia-Induced Oxidative Stress and Insulin Resistance in Myotubes and Skeletal Muscle Tissue by Stimulating Autophagy
  8. Unacylated Ghrelin Reduces Skeletal Muscle Reactive Oxygen Species Generation and Inflammation and Prevents High-Fat Diet–Induced Hyperglycemia and Whole-Body Insulin Resistance in Rodents
  9. Unacylated ghrelin does not alter mitochondrial function, redox state and triglyceride content in rat liver in vivo
  10. In vivo selection of novel biotherapeutics
  11. AAV-mediated in vivo functional selection of tissue-protective factors against ischaemia
  12. In Vivo Therapeutic Potential of Mesenchymal Stromal Cells Depends on the Source and the Isolation Procedure
  13. Neuropilin-1 Identifies a Subset of Bone Marrow Gr1- Monocytes That Can Induce Tumor Vessel Normalization and Inhibit Tumor Growth
  14. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction